Grifols (GIKLY) Current Deferred Revenue (2016 - 2025)

Grifols (GIKLY) reported Current Deferred Revenue of $31.4 million for Q4 2025, down 18.3% on a YoY basis from $38.5 million in Q4 2024, and down 18.3% quarter-over-quarter from $38.5 million in Q4 2024.

Grifols (GIKLY) Current Deferred Revenue (2016 - 2025) Analysis & Trends

Grifols has reported Current Deferred Revenue for 10 years, with the latest figure at $31.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue fell 18.3% year-over-year to $31.4 million; the trailing twelve-month figure through Dec 2025 stood at $31.4 million (down 18.3% YoY), and the FY2025 full-year result was $31.4 million, down 18.3% from the prior year.
  • Current Deferred Revenue for Q4 2025 stood at $31.4 million, down from $38.5 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $38.5 million in Q4 2024, with the low at $28.2 million in Q4 2022.
  • Historically, Current Deferred Revenue has averaged $33.4 million across 5 years, with a median of $31.4 million in 2025.
  • Annual changes were most pronounced in 2021 — Current Deferred Revenue jumped 37.93% — and 2022, when it fell 25.23%.
  • Grifols' Current Deferred Revenue stood at $37.7 million in 2021, then slipped by 25.23% to $28.2 million in 2022, then gained by 10.14% to $31.1 million in 2023, then rose by 23.85% to $38.5 million in 2024, then fell by 18.3% to $31.4 million in 2025.
  • The last three Current Deferred Revenue figures came in at $31.4 million (Q4 2025), $38.5 million (Q4 2024), and $31.1 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 31.43 Mn
Dec 31, 2024 38.47 Mn
Dec 31, 2023 31.06 Mn
Dec 31, 2022 28.20 Mn
Dec 31, 2021 37.72 Mn
Dec 31, 2020 27.34 Mn
Dec 31, 2019 10.84 Mn
Dec 31, 2018 10.17 Mn
Dec 31, 2017 5.04 Mn
Dec 31, 2016 476,158.38